Biotech Values

[DewDiligence]

>Is MNTA your favorite biotech stock right now, Dew?<

MNTA is both the largest and most profitable (+51%) of my current biotech holdings. I made all of my purchases when the stock was cheap, mostly in Nov 2007 immediately following the FDA non-approval of generic Lovenox. After adding shares very recently, my cost basis went up to 5.94 (#msg-33726532).

Perhaps stupidly, I did not sell any shares when the price spiked to $20 last summer. Why didn’t I? The simple answer is that I think MNTA has much more upside than that.